Concepedia

Author

Shelley Zieroth

University of ManitobaORCID

Also Known As

B. Bobadilla, Gordon Moe, Min Zhou, S R Zieroth, S ZIEROTH, S Zieroth, S. Zieroth, S.R. Zieroth, SHELLEY ZIEROTH, Sean Virani

254

Publications

9.2K

Citations

40

H-Index

100

Concepts

All Affiliations

University of ManitobaSt. Boniface HospitalUniversity of British ColumbiaUniversity of AlbertaMontreal Heart Institute
SZ

About

Shelley Zieroth is an author at University of Manitoba specializing in medicine, cardiology, and heart failure.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

35

2.2K

2

Public Health

10

11

1.2K

3

Health Sciences

4

4

168

4

Nursing

2

2

147

5

Business

1

1

99

Shelley Zieroth

×

75

Publications

6.5K

Citations

31

H-Index

YearCitations

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Biykem Bozkurt, Andrew J.S. Coats, Hiroyuki Tsutsui,

European Journal of Heart Failure

2021

1.4K

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink,

Nature Medicine

2022

814

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

Justin A. Ezekowitz, Eileen O’Meara, Michael McDonald,

Canadian Journal of Cardiology

2017

678

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan,

New England Journal of Medicine

2024

530

Empagliflozin after Acute Myocardial Infarction

Javed Butler, W. Schuyler Jones, Jacob A. Udell,

New England Journal of Medicine

2024

223

Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

Stefan D. Anker, Muhammad Usman, Markus S. Anker,

European Journal of Heart Failure

2023

166

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

Justin A. Ezekowitz, Eloisa Colin-Ramírez, Heather J. Ross,

The Lancet

2022

159

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

Robert J. Mentz, Jonathan H. Ward, Adrian F. Hernandez,

Journal of the American College of Cardiology

2023

149

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Eileen O’Meara, Michael McDonald, Michael Chan,

Canadian Journal of Cardiology

2020

120

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications

Gordon W. Moe, Justin A. Ezekowitz, Eileen O’Meara,

Canadian Journal of Cardiology

2014

110

Page 1